Corrigendum to ''Acute administration of 17β-estradiol reduces endothelin-1 release during pacing-induced ischemia" [International Journal of Cardiology 116/1 (2007) 34-39] (DOI:10.1016/j.ijcard.2006.03.025);Acute administration of 17β-estradiol reduces endothelin-1 release during pacing-induced ischemia

International Journal of Cardiology

Volumn 116, Issue 1, 2007, Pages 34-39

  Rosano, Giuseppe M C ^a,b,c   Gebara, Otavio ^a,b,c   Sheiban, Imad ^a,b,c   Silvestri, Antonello ^a,b,c   Wajngarten, Mauricio ^a,b,c   Vitale, Cristiana ^a,b,c   Aldrighi, Jose ^a,b,c   Ramires, Antonio F ^a,b,c   Fini, Massimo ^a,b,c   Mercuro, Giuseppe ^a,b,c  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

17 Estradiol; Coronary artery disease; Estrogen; Ischemia; Women

Indexed keywords

ENDOTHELIN 1; ESTRADIOL; PLACEBO;

ACUTE DRUG ADMINISTRATION; ADULT; AGED; AORTA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY SINUS; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART PACING; HORMONE RELEASE; HUMAN; MENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; METABOLISM; MIDDLE AGED;

BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; DOUBLE-BLIND METHOD; ENDOTHELIN-1; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 33846860612     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.023     Document Type: Erratum

References (37)

1. Bush T.L., Barret-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75 (1987) 1102-1109
2. Gilligan D.M., Quyyumi A.A., and Cannon III R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89 (1994) 2545-2551
3. Rosano G.M.C., Sarrel P.M., Poole-Wilson P.A., and Collins P. Beneficial effect of estrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 342 (1993) 133-136
4. Rosano G.M.C., Mendes Caixeta A., Chierchia S., et al. Short-term antiischemic effect of 17β-estradiol in postmenopausal women with coronary artery disease. Circulation 96 (1997) 2837-2841
5. Weiner C.P., Lizasoian I., Baylis S.A., et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91 (1994) 5212-5216
6. Sudhir K., Jennings G.L., Funder J.W., and Komesaroff P.A. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension 28 (1996) 330-334
7. 2 in porcine coronary artery. Circulation 91 (1995) 2619-2626
8. Jiang C., Poole-Wilson P.A., Sarrel P.M., and Collins P. Effect of estradiol 17 beta on contraction, calcium current and intracellular free calcium in guinea-pig isolated cardiac myocites. Br J Pharmacol 106 (1992) 739-745
9. Jiang C., Sarrel P.M., Lindsay D.C., et al. Endothelium-independent relaxation of rabbit coronary artery by 17β-estradiol in vitro. Br J Pharmacol 104 (1991) 1033-1037
10. Chester A.H., Jiang C., Borland J.A., Yacub M.H., and Collins P. Estrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanism. Coron Artery Dis 6 (1995) 417-422
11. Wendel-Wellner M., Noll T., Konig P., Schmeck J., Koch T., and Kummer W. Cellular localization of the endothelin receptor subtypes ET(A) and ET(B) in the rat heart and their differential expression in coronary arteries, veins, and capillaries. Histochem Cell Biol 118 5 (Nov 2002) 361-369
12. Ray S.G., McMurray J.J., Morton J.J., and Dargie H.J. Circulating endothelin in acute ischemic syndromes. Br Heart J 67 (1992) 383-386
13. Saito Y., Nakao K., Mukoyama M., and Imura N. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 322 (1990) 205
14. Lerman A., Edwards B.S., Hallet J.W., et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325 (1991) 997-1001
15. Vane R.I., Anggarbd E.E., and Botting R.M. Regulatory functions of the vascular endothelium. N Engl J Med 323 (1990) 27-36
16. Kim M.S., Chae H.J., Shin T.Y., Kim H.M., and Kim H.R. estrogen regulates cytokine release in human mast cells. Immunopharmacol Immunotoxicol 23 4 (Nov 2001) 495-504
17. Wilcox J.G., Hatch I.E., Gentzschein E., Stanczyk F.Z., and Lobo R.A. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors. Fertil Steril 67 2 (Feb 1997) 273-277
18. Christodoulakos G., Panoulis C., Kouskouni E., Chondros C., Dendrinos S., and Creatsas G. Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis. Gynecol Endocrinol 16 1 (Feb 2002) 9-17
19. Piercy K.T., Donnell R.L., Kirkpatrick S.S., et al. Effects of estrogen, progesterone, and combination exposure on interleukin-1 beta-induced expression of VCAM-1, ICAM-1, PECAM, and E-selectin by human female iliac artery endothelial cells. J Surg Res 105 2 (Jun 15 2002) 215-219
20. Gilligan D.M., Badar D.M., Panza J.A., Quyyummi A.A., and Cannon III R.O. Acute vascular effects of estrogen in postmenopausal women. Circulation 90 2 (Aug 1994) 786-791
21. Sitges M., Heras M., Roig E., et al. Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. Eur Heart J 22 22 (Nov 2001) 2051-2054
22. Saitta A., Altavilla D., Cucinotta D., et al. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 21 (2001) 1512-1519
23. Juan S.H., Chen J.J., Chen C.H., et al. 17Beta-estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 287 3 (2004) H1254-H1261
24. Tan Z., Wang T.H., Yang D., Fu X.D., and Pan J.Y. Mechanism of 17beta-estradiiol on the production of ET-1 in ovariectomized rats. Life Sci 73 21 (2003) 2665-2674
25. Hosada K., Nakao K., Arai H., et al. Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett 287 (1991) 23-26
26. Ogawa Y., Nakao K., Arai H., et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun 178 (1991) 248-255
27. Haynes W.G., Strachan F.E., and Webb D.J. Endothelin ETA and ETB receptors mediate vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92 (1995) 357-363
28. Zeiher A.M., Ihling C., Pistorius K., et al. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 344 (1994) 1405-1406
29. Omland T., Terje LeR., Aakvaag A., et al. Plasma endothelin determination as a prognostic indicator of one-year mortality after acute myocardial infarction. Circulation 89 (1994) 1573-1579
30. Barber D.A., Michener S.R., Ziesmer S.C., and Miller V.M. Chronic increases in blood flow upregulate endothelin-B receptors in arterial smooth muscle. Am J Physiol 270 (1996) H65-H71
31. Wingrove C.S., and Stevenson J.C. 17Beta-oestradiol inhibits stimulated endothelin release in human vascular endothelial cells. Eur J Endocrinol 137 (1997) 205-208
32. Wang X., Barber D.A., Lewis D.A., et al. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am J Physiol 273 (1997) H1962-H1967
33. Best P.J., Berger P.B., Miller V.M., et al. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 128 (1998) 285-288
34. Maseri A., Abbate A., Baroldi G., et al. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of "preinfarction" angina. N Engl J Med 299 (1978) 1271-1277
35. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-612
36. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 6 (Aug 7 2003) 523-534
37. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 14 (Apr 14 2004) 1701-1712